Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam · Delayed Price · Currency is VND 13,100
0.00 (0.00%)
At close: Aug 13, 2026
HOSE:DBT Revenue
Ben Tre Pharmaceutical JSC had revenue of 227.55B VND in the quarter ending June 30, 2026, a decrease of -6.42%. This brings the company's revenue in the last twelve months to 873.41B, up 1.16% year-over-year. In the year 2025, Ben Tre Pharmaceutical JSC had annual revenue of 860.31B, down -0.93%.
Revenue (ttm)
873.41B
Revenue Growth
+1.16%
P/S Ratio
0.33
Revenue / Employee
1.42B
Employees
677
Market Cap
287.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 860.31B | -8.10B | -0.93% |
| Jan 1, 2025 | 868.41B | 56.80B | 7.00% |
| Dec 31, 2023 | 811.62B | 11.12B | 1.39% |
| Dec 31, 2019 | 800.50B | -9.41B | -1.16% |
| Dec 31, 2018 | 809.91B | 9.80B | 1.22% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 979.05B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.31B |
| Central Pharmaceutical Joint Stock Company No3 | 515.53B |
| Mediplantex National Pharmaceutical JSC | 291.40B |
| Lamdong Pharmaceutical JSC | 262.06B |
| SPM Corporation | 217.45B |
| Cai Lay Veterinary Pharmaceutical JSC | 153.97B |